Finance

Lists
Why is RNTX up 3,21%?
Dive Deeper
RNTX:NASDAQ
Rein Therapeutics Inc
0,79 $
+3,21%
(+0,025) 1D
9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNTX...
Open
0,76 $
High
0,81 $
Low
0,76 $
Mkt. cap
68,43 մլն
Avg. vol.
398,02 հզր
Volume
307,50 հզր
52-wk high
2,18 $
52-wk low
0,69 $
EPS
-1,59 $
Beta
1,36
Shares outstanding
86,27 մլն
No. of employees
10
Open
0,76 $
High
0,81 $
Low
0,76 $
Mkt. cap
68,43 մլն
Avg. vol.
398,02 հզր
Volume
307,50 հզր
52-wk high
2,18 $
52-wk low
0,69 $
EPS
-1,59 $
Beta
1,36
Shares outstanding
86,27 մլն
No. of employees
10
News stories
From web sources and news partners
About Rein Therapeutics Inc
CEO-
Employees10
Founded2001
HeadquartersՕստին, Տեխաս, Միացյալ Նահանգներ
Sector-
Websitereintx.com
Analyst ratings
Based on 2 analysts giving stock ratings to RNTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RNTX in the last 3 months.
Highest
Current 0,79 $
8,00 $ (+907,56%)
Average
6,00 $ (+655,67%)
Lowest
4,00 $ (+403,78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Maintained
8,00 $
+907,6%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
4,00 $
+403,8%
08/17/2026
Kemp Dolliver
Brookline Capital Markets
Hold
Downgraded
-
-
01/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,68 մլն
2,00 մլն
3,07 մլն
3,64 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,81 մլն
1,96 մլն
2,16 մլն
2,44 մլն
Operating expense
5,49 մլն
3,96 մլն
5,23 մլն
6,08 մլն
Total operating expenses
5,49 մլն
3,96 մլն
5,23 մլն
6,08 մլն
Operating income
-5,49 մլն
-3,96 մլն
-5,23 մլն
-6,08 մլն
Other non operating income
-89,00 հզր
-20,00 հզր
-608,00 հզր
-299,00 հզր
EBT including unusual items
-5,58 մլն
-32,68 մլն
-5,84 մլն
-6,38 մլն
EBT excluding unusual items
-5,58 մլն
-3,98 մլն
-5,84 մլն
-6,38 մլն
Income tax expense
-
-712,00 հզր
-
-
Effective tax rate
-
2,18%
-
-
Other operating expenses
-
-
-
-
Net income
-5,58 մլն
-31,97 մլն
-5,84 մլն
-6,38 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,49 մլն
-3,96 մլն
-5,23 մլն
-6,08 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps